ASH Clinical News January 2016 | Page 55

FEATURE physicians who treat hematologic disorders and malignancies may find helpful, according to Susan Doyle-Lindrud, DNP, director of the Doctor of Nursing Practice Program and Oncology Program in the School of Nursing at Columbia University in New York. “Mobile apps have allowed health-care professionals to obtain information from smartphones instantly during patient encounters,” she said. “Access to drug dosing, drug interactions, body surface area calculations, and criteria for grading adverse events has improved efficiency in the clinical setting.” The main selling point of these apps is that they are offered by professional organizations that peer review and update content on a periodic basis, Dr. Doyle-Lindrud explained. She noted that they are also used by cancer physicians as reliable resources for treatment information. And, though there are oncology-specific mobile apps that she recommends, such as medication reminder tools or educational materials from patient-centered websites run by medical societies, uptake among patients is slower. Dr. Krebs sees potential for hematology/ oncology apps that can truly make a difference in patients’ everyday lives. “I think apps could be used to educate patients, especially when they receive an initial diagnosis – that moment when patients say, ‘I have cancer. What now? What happens in the future?’” he said. Ne w In dic at ion RESPOND with the power of signif